Why this drug-research company’s stock had its worst day since 1999

Icon’s stock had its worst of this millennium, as an accounting probe added to investors’ worries about contract research organizations.  

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up For Real Ac.